Europlasma SA
PAR:ALEUP
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.29
83.75
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Europlasma SA
Operating Income
Europlasma SA
Operating Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Europlasma SA
PAR:ALEUP
|
Operating Income
-€26.3m
|
CAGR 3-Years
-31%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-2%
|
|
|
Seche Environnement SA
PAR:SCHP
|
Operating Income
€124.2m
|
CAGR 3-Years
13%
|
CAGR 5-Years
27%
|
CAGR 10-Years
13%
|
|
|
Derichebourg SA
PAR:DBG
|
Operating Income
€181.8m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
15%
|
CAGR 10-Years
11%
|
|
|
Aurea SA
PAR:AURE
|
Operating Income
€57.9m
|
CAGR 3-Years
81%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
31%
|
|
|
Orege SA
PAR:OREGE
|
Operating Income
-€7.8m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
0%
|
|
|
Groupe Pizzorno Environnement SA
PAR:GPE
|
Operating Income
€31.2m
|
CAGR 3-Years
14%
|
CAGR 5-Years
70%
|
CAGR 10-Years
15%
|
|
Europlasma SA
Glance View
Europlasma SA is engaged in the development, manufacturing, and selling of plasma torch technology and industrial equipment. The company is headquartered in Morcenx, Nouvelle-Aquitaine and currently employs 95 full-time employees. The company went IPO on 2009-07-21. The Company’s technology allows converting toxic waste into reusable materials. The firm is composed of four entities, such as Europlasma Torch & Process, which provides engineering consulting for hazardous waste treatment, and sells and licenses its plasma torches and technology; Inertam SAS, which specializes in destruction and valorization of asbestos waste and operates ash melting units; CHO Power SAS, which supplies technological solutions for the efficient transformation of biomass and waste into electric energy and Europe Environnement, which offers ventilation and air cleaning systems for industrial applications.
See Also
What is Europlasma SA's Operating Income?
Operating Income
-26.3m
EUR
Based on the financial report for Dec 31, 2024, Europlasma SA's Operating Income amounts to -26.3m EUR.
What is Europlasma SA's Operating Income growth rate?
Operating Income CAGR 10Y
-2%
Over the last year, the Operating Income growth was -33%. The average annual Operating Income growth rates for Europlasma SA have been -31% over the past three years , -11% over the past five years , and -2% over the past ten years .